Our study establishes Brd4 as an essential metabolic and transcriptional regulator of ATMs and indicates that Brd4 in ATMs could have been a potential therapeutic target for the prevention and treatment of obesity and the associated metabolic diseases. Here, BRD4 is linked to obesity disorder.